These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 7792389

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Prostaglandin E1 in lipid microspheres ameliorates diabetic peripheral neuropathy: clinical usefulness of Semmes-Weinstein monofilaments for evaluating diabetic sensory abnormality.
    Akahori H, Takamura T, Hayakawa T, Ando H, Yamashita H, Kobayashi K.
    Diabetes Res Clin Pract; 2004 Jun; 64(3):153-9. PubMed ID: 15126001
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Lipo-PGE1, a new lipid-encapsulated preparation of prostaglandin E1: placebo-and prostaglandin E1-controlled multicenter trials in patients with diabetic neuropathy and leg ulcers.
    Toyota T, Hirata Y, Ikeda Y, Matsuoka K, Sakuma A, Mizushima Y.
    Prostaglandins; 1993 Nov; 46(5):453-68. PubMed ID: 8278621
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. PGE1 improves diabetic peripheral neuropathy in patients with type 2 diabetes.
    Wu JD, Tao S, Jin X, Jiang LL, Shen Y, Luo Y, Zhang P, Lee KO, Ye L, Ma JH.
    Prostaglandins Other Lipid Mediat; 2016 Nov; 126():24-28. PubMed ID: 27421690
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The therapeutic effect of lipo PGE1 on diabetic neuropathy-changes in endothelin and various angiopathic factors.
    Itoh Y, Yasui T, Kakizawa H, Makino M, Fujiwara K, Kato T, Imamura S, Yamamoto K, Hishida H, Nakai A, Itoh M, Nagasaka A.
    Prostaglandins Other Lipid Mediat; 2001 Oct; 66(3):221-34. PubMed ID: 11577785
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Protective effect of lipid microspheres 1 on myocardial injury following elective percutaneous coronary intervention in patients with angina pectoris: a pilot study.
    Chu-fan L, Xing W, Xun H, Gui-fu W, Cheng-heng H, Zhi-min D.
    J Cardiovasc Med (Hagerstown); 2011 Nov; 12(11):790-4. PubMed ID: 21934521
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Use of the C64 quantitative tuning fork and the effect of niceritrol in diabetic neuropathy.
    Hotta N, Sugimura K, Tsuchida I, Sano T, Koh N, Matsumae H, Sakamoto N.
    Clin Ther; 1994 Nov; 16(6):1007-15. PubMed ID: 7697680
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Reproducibility of different methods for diagnosing and monitoring diabetic neuropathy.
    Nasseri K, Strijers RL, Dekhuijzen LS, Buster M, Bertelsmann FW.
    Electromyogr Clin Neurophysiol; 1998 Nov; 38(5):295-9. PubMed ID: 9741007
    [Abstract] [Full Text] [Related]

  • 17. Lipo-prostaglandin E1 in combination with steroid therapy is effective for treatment of sudden sensorineural hearing loss in Korean patients with Type 2 diabetes.
    Ahn JH, Kim TY, Kim YJ, Han MW, Yoon TH, Chung JW.
    Diabet Med; 2006 Dec; 23(12):1339-43. PubMed ID: 17116185
    [Abstract] [Full Text] [Related]

  • 18. Vasodilating effect and tissue accumulation of prostaglandin E1 incorporated in lipid microspheres on the rat ductus arteriosus.
    Chino Y, Minagawa T, Kohno Y, Fukushima K, Momma K.
    Jpn J Pharmacol; 1999 Sep; 81(1):107-14. PubMed ID: 10580378
    [Abstract] [Full Text] [Related]

  • 19. Components of variance for vibratory and thermal threshold testing in normal and diabetic subjects.
    Gelber DA, Pfeifer MA, Broadstone VL, Munster EW, Peterson M, Arezzo JC, Shamoon H, Zeidler A, Clements R, Greene DA.
    J Diabetes Complications; 1995 Sep; 9(3):170-6. PubMed ID: 7548981
    [Abstract] [Full Text] [Related]

  • 20. [Clinical observation of combined therapeutic effect of prostaglandin E1 and mecobalamin on diabetic peripheral neuropathy].
    Zhu XP, Zhou ZG.
    Hunan Yi Ke Da Xue Xue Bao; 2001 Aug 28; 26(4):343-4. PubMed ID: 12536730
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.